BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Navarro G, Gonzalez A, Sánchez-Morales A, Casajuana-Martin N, Gómez-Ventura M, Cordomí A, Busqué F, Alibés R, Pardo L, Franco R. Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol. J Med Chem 2021;64:9354-64. [PMID: 34161090 DOI: 10.1021/acs.jmedchem.1c00561] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
Number Citing Articles
1 Zagzoog A, Cabecinha A, Abramovici H, Laprairie RB. Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules. Front Pharmacol 2022;13:956030. [DOI: 10.3389/fphar.2022.956030] [Reference Citation Analysis]
2 Lillo J, Raïch I, Silva L, Zafra DA, Lillo A, Ferreiro-vera C, Sánchez de Medina V, Martínez-orgado J, Franco R, Navarro G. Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons. IJMS 2022;23:9695. [DOI: 10.3390/ijms23179695] [Reference Citation Analysis]
3 Ferranti AS, Foster DJ. Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits. Front Neurosci 2022;16:925792. [DOI: 10.3389/fnins.2022.925792] [Reference Citation Analysis]
4 Gado F, Ferrisi R, Polini B, Mohamed KA, Ricardi C, Lucarini E, Carpi S, Domenichini F, Stevenson LA, Rapposelli S, Saccomanni G, Nieri P, Ortore G, Pertwee RG, Ghelardini C, Di Cesare Mannelli L, Chiellini G, Laprairie RB, Manera C. Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands. J Med Chem 2022. [PMID: 35849804 DOI: 10.1021/acs.jmedchem.2c00582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zubrzycki M, Zubrzycka M, Wysiadecki G, Szemraj J, Jerczynska H, Stasiolek M. Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats. IJMS 2022;23:4665. [DOI: 10.3390/ijms23094665] [Reference Citation Analysis]
6 Jirasek P, Jusku A, Simanek V, Frankova J, Storch J, Vacek J. Cannabidiol and periodontal inflammatory disease: A critical assessment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2022. [PMID: 35332345 DOI: 10.5507/bp.2022.012] [Reference Citation Analysis]
7 Morales P, Muller C, Jagerovic N, Reggio PH. Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators. Front Mol Biosci 2022;9:841190. [DOI: 10.3389/fmolb.2022.841190] [Reference Citation Analysis]
8 Franco R, Morales P, Navarro G, Jagerovic N, Reyes-resina I. The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors. Front Pharmacol 2022;13:852631. [DOI: 10.3389/fphar.2022.852631] [Reference Citation Analysis]
9 Kibret BG, Ishiguro H, Horiuchi Y, Onaivi ES. New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders. Int J Mol Sci 2022;23:975. [PMID: 35055161 DOI: 10.3390/ijms23020975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
10 Yuan J, Jiang C, Wang J, Chen CJ, Hao Y, Zhao G, Feng Z, Xie XQ. In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators. Molecules 2022;27:453. [PMID: 35056767 DOI: 10.3390/molecules27020453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Modemann DJ, Maharadhika A, Yamoune S, Kreyenschmidt A, Maaß F, Kremers S, Breunig C, Sahlmann C, Bucerius JA, Stalke D, Wiltfang J, Bouter Y, Müller CE, Bouter C, Meller B. Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114138] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Raïch I, Rivas-Santisteban R, Lillo A, Lillo J, Reyes-Resina I, Nadal X, Ferreiro-Vera C, de Medina VS, Majellaro M, Sotelo E, Navarro G, Franco R. Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors. Pharmacol Res 2021;174:105970. [PMID: 34758399 DOI: 10.1016/j.phrs.2021.105970] [Cited by in F6Publishing: 3] [Reference Citation Analysis]